Jeffrey S. Stein's Insider Trades & SAST Disclosures
Jeffrey S. Stein's most recent trade in Ladder Capital Corp - Ordinary Shares - Class A was a trade of 6,438 Class A Common Stock done . Disclosure was reported to the exchange on Feb. 18, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Jeffrey S. Stein.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Ladder Capital Corp - Ordi... | Jeffrey B. Steiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2025 | 6,438 | 46,792 (0%) | 0% | 0 | Class A Common Stock | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 3,938 | 155,026 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2024 | 4,497 | 151,088 | - | - | Restricted Stock Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 560,888 | 560,888 | - | - | Employee Stock Option (right to buy) | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Purchase of securities on an exchange or from another person at price $ 10.82 per share. | 07 Aug 2024 | 25,000 | 35,000 (0%) | 0% | 10.8 | 270,500 | Common Stock, par value $0.01 per share |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2024 | 3,699 | 146,591 | - | - | Restricted Stock Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 13.21 per share. | 07 Jun 2024 | 8,000 | 24,580 (0%) | 0% | 13.2 | 105,680 | Common Stock |
| Ideaya Biosciences Inc | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2024 | 3,299 | 142,892 | - | - | Restricted Stock Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 1,040,000 | 1,040,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.69 per share. | 11 Mar 2024 | 56,692 | 1,153,693 (2%) | 0% | 0.7 | 39,117 | Common Stock |
| Ladder Capital Corp - Ordi... | B. Jeffrey Steiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2024 | 7,109 | 40,354 (0%) | 0% | 0 | Class A Common Stock | |
| AMBAC Financial Group Inc. | Scott Stein Jeffrey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2024 | 3,147 | 139,593 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Oct 2023 | 3,934 | 136,446 | - | - | Restricted Stock Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.96 per share. | 08 Aug 2023 | 50,000 | 331,602 (0%) | 0% | 1.0 | 47,885 | Common Stock |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2023 | 3,569 | 132,512 | - | - | Restricted Stock Units | |
| Ideaya Biosciences Inc | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 16,200 | 16,200 | - | - | Stock Option (right to buy) | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Apr 2023 | 3,277 | 128,943 | - | - | Restricted Stock Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 543,500 | 543,500 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2023 | 271,750 | 1,202,385 (2%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.04 per share. | 27 Mar 2023 | 50,000 | 281,602 (0%) | 0% | 1.0 | 51,855 | Common Stock |
| Paratek Pharmaceuticals Inc. | Jeffrey Stein | Director | Sale of securities on an exchange or to another person at price $ 1.90 per share. | 21 Feb 2023 | 7,000 | 68,625 (0%) | 0% | 1.9 | 13,300 | Common Stock |
| Ladder Capital Corp - Ordi... | Jeffrey B. Steiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2023 | 6,505 | 33,245 (0%) | 0% | 0 | Class A Common Stock | |
| Paratek Pharmaceuticals Inc. | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 20,000 | 75,625 (0%) | 0% | 0 | Common Stock | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 3,049 | 125,666 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Oct 2022 | 3,567 | 122,617 | - | - | Restricted Stock Units | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 4,538 | 119,050 | - | - | Restricted Stock Units | |
| Ideaya Biosciences Inc | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 4,626 | 114,512 | - | - | Restricted Stock Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 408,742 | 1,063,620 (2%) | 1% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 330,000 | 330,000 | - | - | Employee Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 165,000 | 654,878 (1%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.83 per share. | 31 Mar 2022 | 140,985 | 922,635 (2%) | 0% | 0.8 | 117,018 | Common Stock |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 3,368 | 109,886 | - | - | Restricted Stock Units | |
| Ladder Capital Corp - Ordi... | Jeffrey B. Steiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2022 | 6,372 | 26,740 (0%) | 0% | 0 | Class A Common Stock | |
| Paratek Pharmaceuticals Inc. | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2022 | 20,000 | 55,625 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.59 per share. | 12 Nov 2021 | 50,000 | 465,878 (1%) | 0% | 1.6 | 79,530 | Common Stock |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Nov 2021 | 3,051 | 106,518 | - | - | Restricted Stock Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.72 per share. | 18 Aug 2021 | 40,000 | 405,878 (1%) | 0% | 1.7 | 68,884 | Common Stock |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.79 per share. | 18 Aug 2021 | 10,000 | 415,878 (1%) | 0% | 1.8 | 17,871 | Common Stock |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2021 | 3,437 | 103,467 | - | - | Restricted Stock Units | |
| Ideaya Biosciences Inc | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2021 | 2,936 | 100,030 | - | - | Restricted Stock Units | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 10,000 | 361,878 (0%) | 0% | 0 | Common Stock | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2021 | 525,000 | 525,000 | - | - | Employee Stock Option (right to buy) | |
| Paratek Pharmaceuticals Inc. | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 9,000 | 35,625 (0%) | 0% | 0 | Common Stock | |
| Ladder Capital Corp - Ordi... | Jeffrey B. Steiner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,212 | 20,368 (0%) | 0% | 0 | Class A Common Stock | |
| Paratek Pharmaceuticals Inc. | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2021 | 7,000 | 7,000 | - | - | Stock Option (right to buy) | |
| Cidara Therapeutics Inc | Jeffrey Stein | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.00 per share. | 10 Nov 2020 | 50,000 | 347,878 (0%) | 0% | 2.0 | 100,015 | Common Stock |
| Ideaya Biosciences Inc | Jeffrey Stein | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2020 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| AMBAC Financial Group Inc. | Jeffrey Scott Stein | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Apr 2020 | 11,628 | 97,094 | - | - | Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges